Citations (98)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (38)
Marc Miravitlles, Sudeep Acharya, Bhumika Aggarwal, Frederico LA Fernandes, Jorge Dreyse, José R Jardim, Siwasak Juthong, Gur Levy & Martin Sivori. (2023) Clinical Concepts for Triple Therapy Use in Patients with COPD: A Delphi Consensus. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1853-1866.
Read now
Read now
Alberto Ghiglieri, Monica Messina, Valentina Cenacchi, Claudia Piutti, Flavio Cinato, Giandomenico Brogin & Paola Puccini. (2023) ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß2 adrenoceptor agonist (MABA) radiolabelled at both functional moieties. Xenobiotica 53:4, pages 288-308.
Read now
Read now
Ryuhei Kondo,Jennifer Austin,Mary Akel,Vineet M. Arora,Valerie G. Press,. (2023) Estimated cost-savings from optimizing use of inhaled medications for inpatients with obstructive lung disease. Journal of Asthma 60:2, pages 323-330.
Read now
Read now
David MG Halpin, Robyn Kendall, Soham Shukla, Alan Martin, Dhvani Shah, Dawn Midwinter, Kai M Beeh, Janwillem WH Kocks, Paul W Jones, Chris Compton, Nancy A Risebrough & Afisi S Ismaila. (2022) Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2745-2755.
Read now
Read now
David MG Halpin, Kieran J Rothnie, Victoria Banks, Alexandrosz Czira, Chris Compton, Robert Wood, Theo Tritton, Olivia Massey, Rosie Wild, Neil Snowise, Kirill Nikitin, Raj Sharma, Afisi S Ismaila & Claus F Vogelmeier. (2022) Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2417-2429.
Read now
Read now
David Mannino, Michael Bogart, Guillaume Germain, Shirley P Huang, Afisi S Ismaila, François Laliberté, Young Jung, Sean D MacKnight, Marjorie A Stiegler & Mei Sheng Duh. (2022) Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 491-504.
Read now
Read now
Michael Bogart, Yuhang Liu, Todd Oakland & Marjorie Stiegler. (2022) Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 735-747.
Read now
Read now
Leah B Sansbury, David A Lipson, Chanchal Bains, Glenn A Anley, Kieran J Rothnie & Afisi S Ismaila. (2022) Disease Burden and Healthcare Utilization Among Patients with Chronic Obstructive Pulmonary Disease (COPD) in England. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 415-426.
Read now
Read now
Alpesh N. Amin, Sharon Cornelison, J. Andrew Woods & Nicola A. Hanania. (2022) Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgraduate Medicine 134:2, pages 152-159.
Read now
Read now
Stefania Principe, Salvatore Battaglia, Alida Benfante, Cinzia Arena & Nicola Scichilone. (2022) Does the frequency of switching inhalers represent a predictive factor of exacerbation in asthma?. Journal of Asthma 59:2, pages 370-377.
Read now
Read now
Yating Peng, Jiaxi Duan, Xin Li, Yuqin Zeng, Zijing Zhou, Minghua Deng, Ruoyun Ouyang, Yan Chen, Shan Cai & Ping Chen. (2021) Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2697-2706.
Read now
Read now
Jean Bourbeau, Mona Bafadhel, Neil C Barnes, Chris Compton, Valentina Di Boscio, David A Lipson, Paul W Jones, Neil Martin, Gudrun Weiss & David M G Halpin. (2021) Benefit/Risk Profile of Single-Inhaler Triple Therapy in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 499-517.
Read now
Read now
Mariam Fathima, Zeeta Bawa, Bernadette Mitchell, Juliet Foster, Carol Armour & Bandana Saini. (2021) COPD Management in Community Pharmacy Results in Improved Inhaler Use, Immunization Rate, COPD Action Plan Ownership, COPD Knowledge, and Reductions in Exacerbation Rates. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 519-533.
Read now
Read now
Edward Kerwin, Gregory Feldman, James Pearle, Luis De La Cruz, Melinda Edwards, Carolyn Beaudot & George Georges. (2021) Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 181-190.
Read now
Read now
Kaho Akimoto, Kuniaki Hirai, Tomohiro Matsunaga, Keisuke Kaneko, Hatsuko Mikuni, Tomoko Kawahara, Tomoki Uno, Akiko Fujiwara, Yoshito Miyata, Shin Ohta, Tetsuya Homma, Hideki Inoue, Fumihiro Yamaguchi, Sojiro Kusumoto, Shintaro Suzuki, Akihiko Tanaka & Hironori Sagara. (2020) The Relationship Between the “Adherence Starts with Knowledge-20” Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3201-3211.
Read now
Read now
Marc Miravitlles, Alicia Marín, Alicia Huerta, David Carcedo, Alba Villacampa & Jaume Puig-Junoy. (2020) Estimation of the Clinical and Economic Impact of an Improvement in Adherence Based on the Use of Once-Daily Single-Inhaler Triple Therapy in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1643-1654.
Read now
Read now
Melanie Schroeder, Nicole Benjamin, Laura Atienza, Chandroday Biswas, Alan Martin, John D Whalen, José Luis Izquierdo Alonso, Juan Antonio Riesco Miranda, Juan José Soler-Cataluña, Alicia Huerta & Afisi S Ismaila. (2020) Cost-Effectiveness Analysis of a Once-Daily Single-Inhaler Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease (COPD) Using the FULFIL Trial: A Spanish Perspective. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1621-1632.
Read now
Read now
John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, Deniz Guranlioglu, Martin Jenkins, Neda Stjepanovic & Arushi Bamrara. (2020) Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1529-1543.
Read now
Read now
Faustine Dalon, Gilles Devouassoux, Manon Belhassen, Gaëlle Nachbaur, Camille Correia Da Silva, Lynda Sail, Flore Jacoud, Christos Chouaid & Eric Van Ganse. (2019) Impact of Therapy Persistence on Exacerbations and Resource Use in Patients Who Initiated COPD Therapy. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2905-2915.
Read now
Read now
Faustine Dalon, Nicolas Roche, Manon Belhassen, Maëva Nolin, Hervé Pegliasco, Gaëtan Deslée, Bruno Housset, Philippe Devillier & Eric Van Ganse. (2019) Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1839-1854.
Read now
Read now
José Luis López-Campos, Esther Quintana Gallego & Laura Carrasco Hernández. (2019) Status of and strategies for improving adherence to COPD treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1503-1515.
Read now
Read now
Edward M Kerwin, Thomas M Siler, Samir Arora, Patrick Darken, Earl Rose$suffix/text()$suffix/text() & Colin Reisner. (2018) Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1483-1494.
Read now
Read now
Gary T Ferguson, Roberto Rodriguez-Roisin, Colin Reisner, Andrea Maes, Shahid Siddiqui & Ubaldo J Martin. (2018) Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 945-953.
Read now
Read now
Anthony D D’Urzo, Mario Cazzola, Nicola A Hanania, Roland Buhl & M Reza Maleki-Yazdi. (2018) New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2805-2819.
Read now
Read now
Sinthia Bosnic-Anticevich, Henry Chrystyn, Richard W Costello, Myrna B Dolovich, Monica J Fletcher, Federico Lavorini, Roberto Rodríguez-Roisin, Dermot Ryan, Simon Wan Yau Ming & David B Price. (2017) The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 59-71.
Read now
Read now
Klaus F. Rabe. (2017) GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond. Expert Review of Clinical Pharmacology 10:7, pages 685-698.
Read now
Read now
Jamie Falk, Natalia Dik & Shawn Bugden. (2016) An evaluation of early medication use for COPD: a population-based cohort study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3101-3108.
Read now
Read now
Luigino Calzetta, Chiara Ciaprini, Ermanno Puxeddu & Mario Cazzola. (2016) Olodaterol + tiotropium bromide for the treatment of COPD. Expert Review of Respiratory Medicine 10:4, pages 379-386.
Read now
Read now
Jose Luis Lopez-Campos, Carmen Calero, Cecilia Lopez-Ramirez, Maria Isabel Asensio-Cruz, Eduardo Márquez-Martín & Francisco Ortega-Ruiz. (2015) Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium. Patient Preference and Adherence 9, pages 95-104.
Read now
Read now
Tony D’Urzo, James F Donohue, David Price, Marc Miravitlles & Edward Kerwin. (2015) Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 9:5, pages 519-532.
Read now
Read now
Seoung Ju Park, Barry Make, Craig P. Hersh & Russell P. Bowler. (2015) Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:4, pages 366-373.
Read now
Read now
Fulvio Braido, Federico Lavorini, Francesco Blasi, Ilaria Baiardini & Giorgio Walter Canonica. (2015) Switching treatments in COPD: implications for costs and treatment adherence. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2601-2608.
Read now
Read now
Sanjeevan Muruganandan & Lata Jayaram. (2015) Profile of a fixed-dose combination of tiotropium/olodaterol and its potential in the treatment of COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 1179-1189.
Read now
Read now
A. Ismaila, D. Corriveau, J. Vaillancourt, D. Parsons, A. Dalal, Z. Su & J.S. Sampalis. (2014) Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients. Current Medical Research and Opinion 30:7, pages 1427-1436.
Read now
Read now
Eric D Bateman, Donald A Mahler, Claus F Vogelmeier, Jadwiga A Wedzicha, Francesco Patalano & Donald Banerji. (2014) Recent advances in COPD disease management with fixed-dose long-acting combination therapies. Expert Review of Respiratory Medicine 8:3, pages 357-379.
Read now
Read now
Ronald Dahl, Dalal Jadayel, Vijay KT Alagappan, Hungta Chen & Donald Banerji. (2013) Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 501-508.
Read now
Read now
Mario Cazzola, Paola Rogliani & Maria Gabriella Matera. (2013)
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 14:6, pages 775-781.
Read now
Read now
Rajiv Dhand, Myrna Dolovich, Bradley Chipps, Timothy R. Myers, Ruben Restrepo & Judith Rosen Farrar. (2012) The Role of Nebulized Therapy in the Management of COPD: Evidence and Recommendations. COPD: Journal of Chronic Obstructive Pulmonary Disease 9:1, pages 58-72.
Read now
Read now
Articles from other publishers (60)
Emanuela Resta, Giulia Scioscia, Donato Lacedonia, Carla Maria Irene Quarato, Francesco Panza, Onofrio Resta, Giorgia Lepore, Enrico Buonamico, Valentina Di Lecce, Giovanna Elisiana Carpagnano, Maria Pia Foschino Barbaro & Noemi Rossi. (2022) Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region. BMC Health Services Research 22:1.
Crossref
Crossref
Chang-Hoon Lee, Mi-Sook Kim, See-Hwee Yeo, Chin-Kook Rhee, Heung-Woo Park, Bo-Ram Yang, Joongyub Lee, Eun-Yeong Cho, Xiaomeng Xu, Aldo Amador Navarro Rojas, Sumitra Shantakumar, Dominique Milea & Nam-Kyong Choi. (2022) Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea. Respiratory Research 23:1.
Crossref
Crossref
Afisi S. Ismaila, Katrin Haeussler, Alexandrosz Czira, Ji-Hee Youn, Mia Malmenäs, Nancy A. Risebrough, Jatin Agarwal, Maria Nassim, Raj Sharma, Chris Compton, Claus F. Vogelmeier, MeiLan K. Han & David M. G. Halpin. (2022) Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Triple Therapy Compared with Other Therapies for the Treatment of COPD: A Network Meta-Analysis. Advances in Therapy 39:9, pages 3957-3978.
Crossref
Crossref
Sabina Nduaguba, Jamie C. Barner, Tatiana Makhinova & Kim Roberson. (2021) Medication Therapy Management for Texas MediCAID Patients With Asthma and Chronic Obstructive Pulmonary Disease—A Pilot Study. Journal of Pharmacy Practice 35:4, pages 528-535.
Crossref
Crossref
A. G. Chuchalin, S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, I. V. Leshchenko, S. I. OvcharenkoE. I. Shmelev. (2022) Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA 32:3, pages 356-392.
Crossref
Crossref
David Mannino, Michael Bogart, Benjamin Wu, Guillaume Germain, François Laliberté, Sean D. MacKnight, Young Jung, Marjorie Stiegler & Mei Sheng Duh. (2022) Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study. Respiratory Medicine 197, pages 106807.
Crossref
Crossref
Liansheng Zhang, Xiaoqing Wang, Ye Zhang & Wenyu Chen. (2022) Efficacy and Safety of Single Inhaler Triple Therapy Versus Separate Triple Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis. Clinical Therapeutics 44:6, pages 859-873.
Crossref
Crossref
Benjamin Wu, David Mannino, George Mu, Marjorie Stiegler & Michael Bogart. (2022) Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease. Pulmonary Therapy 8:2, pages 195-208.
Crossref
Crossref
Stefanie C. Nigro & Diana M. Sobieraj. (2021) Budesonide/Glycopyrrolate/Formoterol Fumarate Co-suspension Metered Dose Inhaler: A Triple Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. Annals of Pharmacotherapy 56:5, pages 582-591.
Crossref
Crossref
E. A. Orlova, I. P. Dorfman, M. A. Orlov & M. A. Abdullaev. (2022) The double bronchodilation era: new capabilities in a new drug delivery device. Meditsinskiy sovet = Medical Council:4, pages 128-137.
Crossref
Crossref
MohamedS Al-Moamary, Riyad Al-Lehebi, MajdyM Idrees & MohammedO Zeitouni. (2022) When single-inhaler triple therapy is a preferred option in asthma management?. Annals of Thoracic Medicine 17:4, pages 185.
Crossref
Crossref
Fulvio Braido, Angelo G. Corsico, Davide Paleari, Alessio Piraino, Luca Cavalieri & Nicola Scichilone. (2022) Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution. Therapeutic Advances in Respiratory Disease 16, pages 175346662110660.
Crossref
Crossref
Constança Monteiro, Tiago Maricoto, Filipe Prazeres, Pedro Augusto Simões & José Augusto Simões. (2022) Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respiratory Medicine 191, pages 106724.
Crossref
Crossref
Huanyu Long, Hongxuan Xu, Jean-Paul Janssens & Yanfei Guo. (2021) Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials. Respiratory Research 22:1.
Crossref
Crossref
Arnaud Bourdin, Nicolas Molinari, Gary T. Ferguson, Barinder Singh, Mohd Kashif Siddiqui, Ulf Holmgren, Mario Ouwens, Martin Jenkins & Enrico De Nigris. (2021) Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 38:6, pages 3089-3112.
Crossref
Crossref
David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise & Chris Compton. (2021)
INTREPID: single-
versus
multiple-inhaler triple therapy for COPD in usual clinical practice
. ERJ Open Research 7:2, pages 00950-2020.
Crossref
Crossref
Lindsay G S BengtsonTim BancroftCraig SchillingAmi R BuikemaRichard H Stanford. (2021) Development and validation of a drug adherence index for COPD. Journal of Managed Care & Specialty Pharmacy 27:2, pages 198-209.
Crossref
Crossref
Gary T. Ferguson, Nicola Brown, Chris Compton, Thomas C. Corbridge, Kelly Dorais, Charles Fogarty, Catherine Harvey, Morrys C. Kaisermann, David A. Lipson, Neil Martin, Frank Sciurba, Marjorie Stiegler, Chang-Qing Zhu & David Bernstein. (2020) Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials. Respiratory Research 21:1.
Crossref
Crossref
David A. Lipson, Ruby Birk, Noushin Brealey & Chang-Qing Zhu. (2020) 24-Hour Serial Spirometric Assessment of Once-Daily Fluticasone Furoate/Umeclidinium/Vilanterol Versus Twice-Daily Budesonide/Formoterol in Patients with COPD: Analysis of the FULFIL Study. Advances in Therapy 37:12, pages 4894-4909.
Crossref
Crossref
Bernardino Alcázar-Navarrete & Jose Luis Lopez-Campos. (2020) Comparaciones entre asociaciones de broncodilatadores de larga duración para la enfermedad pulmonar obstructiva crónica. Open Respiratory Archives 2:4, pages 289-293.
Crossref
Crossref
Gary T. Ferguson, Patrick Darken, Shaila Ballal, Mohd Kashif Siddiqui, Barinder Singh, Sumeet Attri, Ulf Holmgren & Enrico de Nigris. (2020) Efficacy of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Other Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting β2-Agonist (ICS/LAMA/LABA) Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Advances in Therapy 37:6, pages 2956-2975.
Crossref
Crossref
José Luis López-Campos, Germán Peces-Barba & Carlos A. Jiménez-Ruiz. (2020) La prescripción con visado de la triple terapia en combinación a dosis fija en España. Archivos de Bronconeumología 56:5, pages 271-272.
Crossref
Crossref
José Luis López-Campos, Germán Peces-Barba & Carlos A. Jiménez-Ruiz. (2020) Controlled Prescription of Triple Fixed-Dose Combination Therapy in Spain. Archivos de Bronconeumología (English Edition) 56:5, pages 271-272.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal & Bernardino Alcázar Navarrete. (2020) Implicaciones clínicas del uso de la triple terapia en combinación de dosis fija en EPOC: del ensayo al paciente. Archivos de Bronconeumología 56:4, pages 242-248.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco-Hernández, Lucas Román Rodríguez, Esther Quintana-Gallego, Carmen Carmona Bernal & Bernardino Alcázar Navarrete. (2020) The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient. Archivos de Bronconeumología (English Edition) 56:4, pages 242-248.
Crossref
Crossref
Garner FaulknerIIII & Christopher J. Moore. 2020. Enhancing Patient Engagement in Pulmonary Healthcare. Enhancing Patient Engagement in Pulmonary Healthcare
243
264
.
Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather & Chris Compton. (2019) Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design. ERJ Open Research 5:4, pages 00061-2019.
Crossref
Crossref
Hae‐Sim Park, Dukyong Yoon, Hyun Young Lee, Ga‐Young Ban, Simon Wan Yau Ming, Joanna Ling Zhi Jie, Victoria Carter, Antony Hardjojo, Job F.M. Van Boven & David B. Price. (2019) Real‐life effectiveness of inhaler device switch from dry powder inhalers to pressurized metred‐dose inhalers in patients with asthma treated with ICS/LABA. Respirology 24:10, pages 972-979.
Crossref
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Crossref
Priti P. Pednekar, Tamás Ágh, Maria Malmenäs, Amit D. Raval, Bryan M. Bennett, Bijan J. Borah, David S. Hutchins, Elizabeth Manias, Allison F. Williams, Mickaël Hiligsmann, Adina Turcu-Stiolica, John E. Zeber, Lusine Abrahamyan, Thomas J. Bunz & Andrew M. Peterson. (2019) Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health 22:2, pages 139-156.
Crossref
Crossref
Andrea Maes, Paolo DePetrillo, Shahid Siddiqui, Colin Reisner & Paul Dorinsky. (2018) Pharmacokinetics of Co‐Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed‐Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single‐Dose, Crossover Study in Healthy Adults. Clinical Pharmacology in Drug Development 8:2, pages 223-233.
Crossref
Crossref
Paul Dorinsky, Paolo DePetrillo, Shahid Siddiqui, Andrea Maes & Colin Reisner. (2018) Safety and pharmacokinetics of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler (BGF MDI) in healthy adult subjects of Japanese descent. Pulmonary Pharmacology & Therapeutics 51, pages 18-25.
Crossref
Crossref
Jee-Ae Kim, Min Kyoung Lim, Kunil Kim, JuHee Park & Chin Kook Rhee. (2017) Adherence to Inhaled Medications and its Effect on Healthcare Utilization and Costs Among High-Grade Chronic Obstructive Pulmonary Disease Patients. Clinical Drug Investigation 38:4, pages 333-340.
Crossref
Crossref
Steven D. Deas & Nikhil Huprikar. (2018) Dual bronchodilator therapy for chronic obstructive pulmonary disease. Current Opinion in Pulmonary Medicine 24:2, pages 130-137.
Crossref
Crossref
Alan Kaplan & David Price. (2018) Matching Inhaler Devices with Patients: The Role of the Primary Care Physician. Canadian Respiratory Journal 2018, pages 1-9.
Crossref
Crossref
Glyn Taylor, Simon Warren, Sarvajna Dwivedi, Mark Sommerville, Lauren Mello, Chad Orevillo, Andrea Maes, Ubaldo J. Martin & Omar S. Usmani. (2018) Gamma scintigraphic pulmonary deposition study of glycopyrronium/formoterol metered dose inhaler formulated using co-suspension delivery technology. European Journal of Pharmaceutical Sciences 111, pages 450-457.
Crossref
Crossref
Colin Reisner, Leonardo M. Fabbri, Edward M. Kerwin, Charles Fogarty, Selwyn Spangenthal, Klaus F. Rabe, Gary T. Ferguson, Fernando J. Martinez, James F. Donohue, Patrick Darken, Earl St. Rose, Chad Orevillo, Shannon Strom, Tracy Fischer, Michael Golden & Sarvajna Dwivedi. (2017) A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref
Claudia Gregoriano, Thomas Dieterle, Selina Dürr, Isabelle Arnet, Kurt E Hersberger & Jörg D Leuppi. (2017) Impact of an Electronic Monitoring Intervention to Improve Adherence to Inhaled Medication in Patients with Asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial. JMIR Research Protocols 6:10, pages e204.
Crossref
Crossref
Jennifer S. Albrecht, Bilal Khokhar, Ting-Ying Huang, Yu-Jung Wei, Ilene Harris, Patience Moyo, Peter Hur, Susan W. Lehmann, Giora Netzer & Linda Simoni-Wastila. (2017) Adherence and healthcare utilization among older adults with COPD and depression. Respiratory Medicine 129, pages 53-58.
Crossref
Crossref
José Luis Lopez-Campos, Eduardo Marquez-Martín & Francisco Ortega-Ruiz. (2017) Terapia triple vs. tripe terapia en EPOC. Archivos de Bronconeumología 53:8, pages 419-420.
Crossref
Crossref
José Luis Lopez-Campos, Eduardo Marquez-Martín & Francisco Ortega-Ruiz. (2017) Triple Therapy vs Triple Therapy in COPD. Archivos de Bronconeumología (English Edition) 53:8, pages 419-420.
Crossref
Crossref
Nicola A. Hanania, Donald P. Tashkin, Edward M. Kerwin, James F. Donohue, Michael Denenberg, Denis E. O'Donnell, Dean Quinn, Shahid Siddiqui, Chad Orevillo, Andrea Maes & Colin Reisner. (2017) Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary disease. Respiratory Medicine 126, pages 105-115.
Crossref
Crossref
Anthony D'Urzo, Stephen Rennard, Edward Kerwin, James F. Donohue, Alejhandra Lei, Eduard Molins & Anne Leselbaum. (2017) A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease. Respiratory Medicine 125, pages 39-48.
Crossref
Crossref
Sandra Søgaard Tøttenborg, Peter Lange, Søren Paaske Johnsen, Henrik Nielsen, Truls Sylvan Ingebrigtsen & Reimar Wernich Thomsen. (2016) Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPD. Respiratory Medicine 119, pages 160-167.
Crossref
Crossref
MeiLan K Han, Carlos H Martinez, David H Au, Jean Bourbeau, Cynthia M Boyd, Richard Branson, Gerard J Criner, Ravi Kalhan, Thomas J Kallstrom, Angela King, Jerry A Krishnan, Suzanne C Lareau, Todd A Lee, Kathleen Lindell, David M Mannino, Fernando J Martinez, Catherine Meldrum, Valerie G Press, Byron Thomashow, Laura Tycon, Jamie Lamson Sullivan, John Walsh, Kevin C Wilson, Jean Wright, Barbara Yawn, Patrick M Zueger, Surya P Bhatt & Mark T Dransfield. (2016) Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. The Lancet Respiratory Medicine 4:6, pages 473-526.
Crossref
Crossref
Mark L Levy, P N R Dekhuijzen, P J Barnes, M Broeders, C J Corrigan, B L Chawes, L Corbetta, J C Dubus, Th Hausen, F Lavorini, N Roche, J Sanchis, Omar S Usmani, J Viejo, W Vincken, Th Voshaar, G K Crompton & Soren Pedersen. (2016) Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila & Martin O’Leary. (2015) Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK. Cost Effectiveness and Resource Allocation 13:1.
Crossref
Crossref
Eric D. Bateman, Kenneth R. Chapman, Dave Singh, Anthony D. D’Urzo, Eduard Molins, Anne Leselbaum & Esther Garcia Gil. (2015) Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respiratory Research 16:1.
Crossref
Crossref
Deborah Duncan. (2015) Medication adherence in chronic obstructive pulmonary disease. Practice Nursing 26:10, pages 493-498.
Crossref
Crossref
Jutta Beier. (2015) A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of chronic obstructive pulmonary disease. Clinical Investigation 5:8, pages 691-700.
Crossref
Crossref
Lisa Cicutto. (2015) Ease of Delivery Is Not So Easy. Chest 147:5, pages 1204-1206.
Crossref
Crossref
Deborah Duncan. (2015) Medication adherence in chronic obstructive pulmonary disease. Nurse Prescribing 13:4, pages 172-177.
Crossref
Crossref
Mario Cazzola, Kai M. Beeh, David Price & Nicolas Roche. (2015) Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD. Pulmonary Pharmacology & Therapeutics 31, pages 68-78.
Crossref
Crossref
Katie E. Baker, Sara J. Bonvini, Chantal Donovan, Rachel E. Foong, Bing Han, Aruni Jha, Yasin Shaifta, Marieke Smit, Jill R. Johnson & Lyn M. Moir. (2014) Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models. Pulmonary Pharmacology & Therapeutics 29:2, pages 181-198.
Crossref
Crossref
Ariane K. Kawata, Leah Kleinman, Gale Harding & Sulabha Ramachandran. (2014) Evaluation of Patient Preference and Willingness to Pay for Attributes of Maintenance Medication for Chronic Obstructive Pulmonary Disease (COPD). The Patient - Patient-Centered Outcomes Research 7:4, pages 413-426.
Crossref
Crossref
Donald Banerji, Robert Fogel & Kai-Michael Beeh. (2014) Dual bronchodilation for the treatment of chronic obstructive pulmonary disease: a review of the latest clinical data. Clinical Investigation 4:6, pages 511-533.
Crossref
Crossref
James E. Frampton. (2014) QVA149 (Indacaterol/Glycopyrronium Fixed-Dose Combination): A Review of Its Use in Patients with Chronic Obstructive Pulmonary Disease. Drugs 74:4, pages 465-488.
Crossref
Crossref
Mika J. Mäkelä, Vibeke Backer, Morten Hedegaard & Kjell Larsson. (2013) Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respiratory Medicine 107:10, pages 1481-1490.
Crossref
Crossref
Timothy E. Albertson, Michael Schivo, Amir A. Zeki, Samuel Louie, Mark E. Sutter, Mark Avdalovic & Andrew L. Chan. (2013) The Pharmacological Approach to the Elderly COPD Patient. Drugs & Aging 30:7, pages 479-502.
Crossref
Crossref
Andrew P. Yu, Annie Guérin, Diego Ponce de Leon, Karthik Ramakrishnan, Eric Q. Wu, Michelle Mocarski, Steven I. Blum & Juliana Setyawan. (2011) Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD. Respiratory Medicine 105:12, pages 1861-1871.
Crossref
Crossref